| ARKR |
Ark Restaurants Corp. |
Common Stock, par value $0.01 per share |
17.3% |
$5.7M |
$440K |
622K |
+8.37% |
Thomas A. Satterfield, Jr. |
Aug 5, 2025 |
| CRIS |
Curis, Inc. |
Common Stock, par value $0.01 per share |
9.9% |
$1.51M |
$358K |
1.04M |
+31% |
Thomas A. Satterfield, Jr. |
Mar 31, 2025 |
| SCND |
Scientific Industries, Inc. |
Common Stock, $.05 par value |
9.9% |
$1.18M |
|
1.14M |
|
Thomas A. Satterfield, Jr. |
Dec 31, 2024 |
| BCDA |
BioCardia, Inc. |
Common Stock, par value $0.001 per share |
9.9% |
$1.15M |
$398K |
592K |
+52.6% |
Thomas A. Satterfield, Jr. |
Jun 30, 2025 |
| OSTX |
OS Therapies Incorporated |
Common Stock, par value $0.001 per share |
9.4% |
$7.26M |
$4.31M |
3.12M |
+146% |
Thomas A. Satterfield, Jr. |
Jun 30, 2025 |
| NVNO |
enVVeno Medical Corporation |
Common Stock, $0.00001 par value per share |
9% |
$1.35M |
|
1.82M |
|
Thomas A. Satterfield, Jr. |
Nov 14, 2025 |
| INTT |
inTest Corporation |
Common Stock, par value $0.01 per share |
8% |
$5.87M |
$1.15M |
1M |
+24.3% |
Thomas A. Satterfield, Jr. |
Jun 30, 2025 |
| CTSO |
CytoSorbents Corporation |
Common Stock, par value $0.001 per share |
6.56% |
$4M |
|
4M |
|
Thomas A. Satterfield, Jr. |
Jan 13, 2025 |
| CHRS |
Coherus BioSciences, Inc. |
Common Stock, $0.0001 par value per share |
5.2% |
$5.05M |
|
6.01M |
|
Thomas A. Satterfield, Jr. |
Apr 14, 2025 |
| EDSA |
Edesa Biotech, Inc. |
Common Stock, without par value |
0% |
$0 |
-$534K |
0 |
-100% |
Thomas A. Satterfield, Jr. |
Feb 13, 2025 |